MYPROMS-ES02: Safety and Efficacy of Basiliximab, Cyclosporine Microemulsion and Enteric-coated Mycophenolate Sodium (EC-MPS) Versus EC-MPS and Steroid Therapy in Kidney Transplant Recipients Who Are Hepatitis C Positive

Autores
Categoría Estudio primario
Registro de estudiosclinicaltrials.gov
Año 2004

Este artículo no está incluido en ninguna revisión sistemática

Cargando información sobre las referencias
To prospectively evaluate in de novo kidney transplant recipients, hepatitis C positive, the clinical outcomes of an immunosuppressive regimen of EC-MPS free of steroids in comparison with a regimen of EC-MPS with standard steroids, as measured by the hepatic function tests (ALT/AST) after 12 months treatment.
Epistemonikos ID: e6c028cc56d2d86a9a435be23f2577644d440583
First added on: May 04, 2024